Albuterol syrup in the treatment of asthma.

Author: BiermanC W, FurukawaC T, PiersonW E, ShapiroG G

Paper Details 
Original Abstract of the Article :
This study evaluated the administration of albuterol syrup (0.1 mg/kg/6 hr) or placebo to 2- to 6-year old children whose extrinsic asthma was treated with maintenance theophylline in a prerandomized, double-blind crossover study design. Albuterol/theophylline treatment produced peak expiratory flow...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/0091-6749(85)90707-9

データ提供:米国国立医学図書館(NLM)

Albuterol Syrup: A Breath of Fresh Air for Young Asthmatics

Asthma, a chronic respiratory condition that affects millions of children worldwide, can be a challenging illness to manage. This research investigates the efficacy of albuterol syrup in conjunction with theophylline for the treatment of asthma in young children. The study, like a trek through a vast desert landscape, seeks to improve the quality of life for these vulnerable individuals.

Improved Asthma Control

The results demonstrated that the addition of albuterol syrup to theophylline therapy significantly improved asthma control in children aged 2 to 6 years. The study revealed a significant improvement in pulmonary function, a decrease in theophylline dosage requirements, and a reduction in asthma symptoms. This is like discovering a hidden oasis in the desert of asthma, providing much-needed relief and a path to better health. It offers a valuable tool for pediatricians, improving the management of asthma in young children.

A Brighter Future for Young Asthmatics

The findings of this study offer a glimmer of hope for young asthmatics, providing a more effective and well-tolerated treatment option. It is like a warm desert breeze, bringing a sense of comfort and well-being to those struggling with this chronic condition. This research underscores the importance of continued research and innovation in the field of pediatric asthma, seeking to improve the lives of children affected by this debilitating disease.

Dr. Camel's Conclusion

This study serves as a reminder of the enduring power of medical research to improve the lives of children. The development of safe and effective treatments for asthma is a testament to the dedication and perseverance of medical professionals. We must continue to invest in research, seeking to provide a brighter future for all children suffering from chronic illnesses.

Date :
  1. Date Completed 1985-09-13
  2. Date Revised 2019-07-23
Further Info :

Pubmed ID

3894481

DOI: Digital Object Identifier

10.1016/0091-6749(85)90707-9

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.